Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Return on Equity (2019 - 2025)

Eton Pharmaceuticals' Return on Equity history spans 7 years, with the latest figure at 0.28% for Q3 2025.

  • For Q3 2025, Return on Equity rose 9.0% year-over-year to 0.28%; the TTM value through Sep 2025 reached 0.28%, up 9.0%, while the annual FY2024 figure was 0.19%, 13.0% down from the prior year.
  • Return on Equity for Q3 2025 was 0.28% at Eton Pharmaceuticals, down from 0.17% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.13% in Q3 2023 and bottomed at 0.9% in Q2 2022.
  • The 5-year median for Return on Equity is 0.37% (2024), against an average of 0.38%.
  • The largest annual shift saw Return on Equity soared 487bps in 2021 before it plummeted -63bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.12% in 2021, then tumbled by -533bps to 0.74% in 2022, then surged by 92bps to 0.06% in 2023, then tumbled by -227bps to 0.19% in 2024, then tumbled by -50bps to 0.28% in 2025.
  • Per Business Quant, the three most recent readings for ETON's Return on Equity are 0.28% (Q3 2025), 0.17% (Q2 2025), and 0.19% (Q1 2025).